IP Library Granted Patent US 7,771,414
Granted Patent B2
US 7,771,414 · App. 11/410,221 · Granted Aug 10, 2010

Controlled release devices for therapeutic treatments of spinal discs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,771,414
App. No.
11/410,221
Granted
Aug 10, 2010
Kind
B2
Abstract

A device includes a first reservoir configured to include a degrading agent, a first valve in fluid communication with the first reservoir, and a reservoir driver configured to manipulate the first reservoir to effect a first reservoir condition based on a first tissue condition. The first valve is configured to open in response to the first reservoir condition associated with the first reservoir.

Claims (18)

1. A device comprising:

a first reservoir;

a second reservoir;

a first valve in fluid communication with the first reservoir, the first valve configured to open based on a first tissue condition of pressure or hydration;

a second valve in fluid communication with the second reservoir, the second valve configured to open based on a second tissue condition and wherein the second valve is configured to close based on the first tissue condition; and

a first osmotic driver coupled to the first reservoir, wherein the first osmotic driver is configured to adjust a pressure of the first reservoir based on a condition of a tissue of pressure or hydration.

2. The device of claim 1 , wherein the first valve is configured to close based on the second tissue condition.

3. The device of claim 1 , wherein the first reservoir is configured to include a first agent, wherein the first agent is a first stimulating agent.

4. The device of claim 3 , wherein the second reservoir is configured to include a second agent, and wherein the second agent is a second stimulating agent.

5. The device of claim 4 , wherein the first stimulating agent is a regenerating agent.

6. The device of claim 4 , wherein the second stimulating agent is a therapeutic agent.

7. The device of claim 3 , wherein the second reservoir is configured to include a second agent, and wherein the second agent is a degrading agent.

8. The device of claim 7 , wherein the degrading agent is selected from the group consisting of chymopapain, collagenase, chondroitinase, keratanase, human proteolytic enzymes, papaya protenase, or any combination thereof.

9. The device of claim 1 , wherein the first tissue condition is associated with a low average pressure in a tissue.

10. The device of claim 1 , wherein the second tissue condition is associated with a high average pressure in a tissue.

11. The device of claim 1 , wherein the first osmotic driver is coupled to the second reservoir.

12. The device of claim 1 , further comprising a second osmotic driver coupled to the second reservoir.

13. The device of claim 12 , wherein the first and second osmotic drivers have a different response to a condition of a tissue.

Assignments (2)
MERGER Recorded Mar 27, 2009
From: SDGI HOLDING, INC.
To: WARSAW ORTHOPEDIC, INC.
Reel/Frame 022471/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2006
From: TRIEU, HAI H.
To: SDGI HOLDINGS, INC.
Reel/Frame 017816/0074 →